China Biologic Products Holdings, Inc.
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Crestview_Partners
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:country |
gptkb:China
|
| gptkbp:founded |
2002
|
| gptkbp:headquartersLocation |
gptkb:Beijing,_China
|
| https://www.w3.org/2000/01/rdf-schema#label |
China Biologic Products Holdings, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:product |
gptkb:human_albumin
coagulation factor VIII intravenous immunoglobulin (IVIG) other plasma-derived products |
| gptkbp:serves |
hospitals
healthcare institutions disease control agencies |
| gptkbp:specializesIn |
plasma-based biopharmaceutical products
|
| gptkbp:stockSymbol |
CBPO
|
| gptkbp:website |
http://www.chinabiologic.com/
|
| gptkbp:bfsParent |
gptkb:CBPG
|
| gptkbp:bfsLayer |
7
|